|
 |
| |
| |
| Licensing & Royalties >> Licensing Opportunities >> Abstract Details |
|
| |
| AT8, a Hybridoma Cell Line Producing a Monoclonal Antibody (MAb) Specific for Ly49G, a Mouse Natural Killer (NK) Cell Receptor |
Description of Invention:
This MAb is useful for identifying and isolating specific subpopulations of mouse NK cells using flow cytometry and fluorescence activated cell sorting (FACS). The AT8 antibody is also useful as a reagent to study the innate immune system using mouse models. This antibody has been described in Makrigiannis et al., "Independent Control of Ly49g Alleles: Implications for NK Cell Repertoire Selection and Tumor Cell Killing," J. Immunol. 2004 172:1414-1425.
Inventors:
Andrew P Makrigiannis (NCI)
Patent Status:
HHS, Reference No. E-131-2004/0
For Licensing Information Please Contact:
Cristina Thalhammer-Reyero Ph.D., M.B.A.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325
Room 33,
Rockville, MD 20852
United States
Email: thalhamc@mail.nih.gov
Phone: 301-435-4507
Fax: 301-402-0220
Ref No: 928
Updated: 05/2004
|
|
|
|
| |
|
|
|
|